Eye Care Market (2026 - 2033) Size, Share & Trends Analysis Report By Product (Contact Lens, Ocular Health Products), By Mode Of Purchase (Over-The-Counter, Prescribed), By Distribution Channel (Hospitals & Clinics, Retail Stores), By Region, And Segment Forecasts

Eye Care Market Summary

The global eye care market size was estimated at USD 22.0 billion in 2025 and is projected to reach USD 28.8 billion by 2033, growing at a CAGR of 3.4% from 2026 to 2033. The market is driven by a rising number of people suffering from eye-related disorders, an aging population, technological advancements, and increasing awareness about eye care.

The increasing prevalence of vision disorders, particularly vision impairment and presbyopia, presents a significant opportunity for the industry. With around 2.2 billion people worldwide suffering from vision impairment, and an estimated 1.09 billion cases of presbyopia affecting the middle-aged to elderly population, the demand for vision care services and products is poised to grow. The primary causes of vision impairment such as refractive errors and cataracts are largely preventable or treatable, indicating a vast untapped market for corrective lenses, surgical procedures, and other interventions. The economic burden of vision impairment, estimated at USD 411 billion annually in lost productivity, underscores the importance of accessible and affordable care solutions. The WHO’s SPECS 2030 initiative aims to increase access to refractive error services by 40%, further highlighting the industry’s potential. Given the demographic shifts towards an aging population and the rising awareness of eye health, the industry is well-positioned for growth, driven by the need to address the global vision disorder epidemic.

Cataract surgery is the number one surgery performed globally, with 28 million procedures each year. But only 10-15% of patients are getting advanced optical IOLs specifically designed for astigmatism and presbyopia.

Jacqueline Henderson, President Vision, EMEA, Johnson & Johnson

Technological advancements in vision care, including smart contact lenses, drug-delivering contact lenses, multifocal and extended depth of focus (EDOF) intraocular lenses (IOLs), automated refraction systems, and digital retinal imaging, represent significant drivers for the industry. These innovations enhance the functionality and efficacy of products, as well as treat and manage ocular health. For instance, smart contact lenses promise to revolutionize diabetes management by enabling continuous glucose monitoring, while drug-delivering contact lenses offer a novel approach to treating ocular surface diseases. Multifocal and EDOF IOLs improve post-cataract surgery outcomes by providing clearer vision at various distances, reducing dependency on reading glasses. For instance, in June 2023, Novaliq announced FDA approval of VEVYE (Cyclosporine Ophthalmic Solution) 0.1% for treating dry eye disease signs and symptoms, marking the first cyclosporine solution with proven efficacy in 4 weeks. In addition, in February 2024, Johnson & Johnson MedTech launched the TECNIS PureSee presbyopia-correcting intraocular lens in EMEA. This next-generation lens features a purely refractive design, delivering uninterrupted, high-quality vision with excellent low-light performance and minimal visual symptoms, enhancing cataract surgery outcomes for patients and surgeons. In addition, automated refraction systems streamline the prescription process, and digital retinal imaging aids during early detection and monitoring of diseases. These advancements drive the market forward by addressing unmet needs, and opening new markets, thereby fostering innovation and growth in the sector. 

“We are starting the new year with the launch of another complex high-value product, which will help drive our continued growth, ophthalmic products represent a less crowded and more durable category, and we continue to expand our portfolio of affordable medicines.”

” Andy Boyer, Executive Vice President, Chief Commercial Officer - Generics. “

Government initiatives involving the Vision and Eye Health Surveillance System (VEHSS) have driven advancements in the industry since its inception. VEHSS has evolved to include additional years of data, condition-specific composite estimates for vision impairment, blindness, and age-related macular degeneration, along with mapping and other data visualization capabilities. In 2022, VEHSS expanded its capabilities to stratify American Community Survey estimates of vision impairment and blindness by social determinants of health, including poverty, unemployment, and other disabilities.

This initiative has resulted in numerous peer-reviewed publications and reports, highlighting its impact on understanding, and addressing vision loss and conditions in the U.S. In addition, rising public health initiatives and a focus on preventive healthcare are making people more aware of the importance of regular eye exams. In May 2024, The Canadian Association of Optometrists (CAO) launched a nationwide digital campaign to remind people about the importance of eye health. This campaign, supported by provincial optometry groups, encourages Canadians to schedule regular eye exams with their optometrist.

Market Concentration & Characteristics

The eye care industry displays a moderate level of concentration, with several key players dominating the market growth. Characteristics include stringent regulatory standards ensuring product quality and safety. Moreover, the industry benefits from increasing demand for ocular health care globally due to factors like rising prevalence of vision disorders and expanding aging population. However, challenges like high initial investment costs and complex regulatory requirements impact market entry.

The market has seen a high degree of innovation, with advancements in technology and methodologies, driven by a combination of research, regulatory approvals, and market demand. Innovations span from smart contact lenses that monitor glucose levels, to drug-delivering contact lenses for ocular surface diseases that enhance post-cataract surgery outcomes. In addition, the integration of artificial intelligence (AI) in diagnostic imaging and screening solutions has improved the early detection and management of retinal disorders, glaucoma, and diabetic retinopathy. Companies are also focusing on minimally invasive surgical technologies, advanced intraocular lenses (IOLs), and digital ophthalmic platforms to enhance patient comfort, treatment precision, and clinical efficiency. Furthermore, increasing investments in teleophthalmology and portable eye care devices are expanding access to eye care services, particularly in remote and underserved regions, thereby supporting overall market growth.

Partnerships and collaborations play an important role in the market, enabling companies to expand product reach, strengthen ophthalmology expertise, and develop advanced vision care solutions. Strategic alliances between medical device manufacturers, pharmaceutical companies, hospitals, and technology firms are accelerating the development of AI-powered diagnostics, teleophthalmology platforms, and next-generation surgical devices. Collaborations also support clinical trials, regulatory approvals, and commercialization efforts, helping companies improve patient outcomes and broaden access to innovative eye care treatments globally.

Regulations influence the market by setting standards for product safety, efficacy, and quality. They ensure that new technologies and treatments meet stringent criteria before reaching consumers, safeguarding patient health and trust in medical devices. Regulatory bodies like the U.S. FDA oversee the approval of new drugs, devices, and therapies, including smart contact lenses, drug-delivering contact lenses, and at-home digital vision care technologies. In addition, evolving regulatory frameworks related to digital health, AI-based diagnostics, and data privacy are shaping product development and commercialization strategies. Compliance with international quality standards and clinical validation requirements also increases the credibility and adoption of advanced ophthalmic products.

Product substitutes in the eye care industry include traditional eyeglasses, over-the-counter eye drops, generic ophthalmic drugs, and alternative vision correction procedures such as refractive surgeries. Consumers may also opt for non-surgical vision correction methods instead of premium ophthalmic devices or advanced surgical treatments due to affordability concerns. The availability of low-cost substitutes and increasing competition from regional manufacturers can impact the adoption of premium eye care products, particularly in price-sensitive markets. However, continuous technological advancements and improved treatment outcomes are helping advanced eye care solutions maintain strong market demand.

The industry is expanding regionally due to rising global demand. Manufacturers are establishing a presence in emerging markets to meet growing needs for vision correction solutions, cataract treatment, and digital eye care services. Companies are increasingly focusing on Asia Pacific, Latin America, and the Middle East & Africa due to improving healthcare infrastructure, rising awareness regarding eye health, and increasing healthcare expenditure. For instance, in Janaury 2024 NVISION Eye Centers expanded in Texas through a joint venture with Parkhurst NuVision (PNV), the partnership aims to enhance patient care and expand services across Texas, leveraging NVISION's management expertise and capital for growth. 

“This partnership is an important step in our continued growth and expansion throughout the United States. We have admired what Dr. Parkhurst has built and together we look forward to partnering with other exceptional physician practices throughout Texas”

“Chris Karkenny, CEO of NVISION”

Mergers and acquisitions in the industry are rising due to the need for research and development, reflecting the industry's dynamic nature. Companies are leveraging M&A activities to innovate and offer advanced solutions that meet the evolving needs of healthcare professionals. For instance, in May 2024, Visibly acquired Lensabl to enhance its platform with optical e-commerce, aiming to make vision care more accessible. Lensabl's expertise includes direct-to-consumer sales and a growing B2B sector, offering white-label e-commerce solutions and modernized vision plans. This merger combines Lensabl's retail offerings with Visibly's telehealth services, promising broader access to affordable vision care..

“"At Lensabl, we believe in leveraging technology to make access to vision care easier and more affordable, having worked with Visibly for years, we believe by joining forces, our complimentary offerings can help their existing customers provide a more comprehensive range of vision services to the end-consumer."

“Andy Bilinsky, CEO of Lensabl”

Product Insights

The contact lens segment accounted for the largest market share of 35.9% in 2025. Contact lens offers convenient alternative to traditional eyeglasses for vision correction. Their popularity stems from factors such as improved comfort, enhanced aesthetics, and technological advancements. With options ranging from daily disposables to specialized lenses for various vision conditions, contact lenses cater to a diverse consumer base seeking both functional and lifestyle-oriented solutions for their visual needs. The segment is also witnessing strategic product launches aimed at strengthening innovation and expanding market presence. For instance, in February 2026, Johnson & Johnson Vision launched ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM, the first daily disposable multifocal toric contact lens designed for individuals with both astigmatism and presbyopia.

The ocular health products segment is expected to exhibit the fastest CAGR of 3.8% during the forecast period, driven by increasing awareness of ocular health and preventive care. These products encompass a wide range of solutions, including drops, supplements, and protective eyewear, designed to promote eye wellness and address common conditions such as dryness, irritation, and fatigue. As consumers prioritize proactive measures to maintain optimal vision and overall eye health, the demand for ocular health products is expected to continue rising, shaping the landscape of the industry.

Mode Of Purchase Insights

The prescribed products segment accounted for the largest market share in 2025 and is expected to witness the fastest CAGR over the forecast period, necessitating professional diagnosis and supervision for treatment. These products, including prescription eyeglasses, specialized lenses, and medicated drops, address various vision impairments and ocular conditions. By requiring a prescription, they ensure tailored solutions and proper management, instilling trust and reliability among consumers. Despite the rise of over-the-counter options, prescribed products remain essential for addressing complex vision issues and maintaining optimal care standards.

The over-the-counter products segment is expected to exhibit significant growth during the forecast period, fueled by advancements in self-care options and consumer preferences for convenience. Ranging from non-prescription eyewear to lubricating drops and nutritional supplements, OTC products offer accessible solutions for common concerns like dryness, redness, and allergies. With the convenience of direct purchase without a prescription, they empower consumers to take proactive measures in managing their ocular health, contributing to the expanding landscape of self-directed wellness and personalized healthcare.

Distribution Channel Insights

The hospitals and clinics segment accounted for the largest market share in 2025. Hospitals & clinics play a key role in distributing vision care products, especially prescribed items requiring professional diagnosis and supervision. These establishments offer comprehensive care services, including consultations, diagnostics, and treatment, ensuring personalized solutions for patients' vision needs. With access to specialized equipment and expertise, hospitals and clinics serve as trusted hubs for addressing complex conditions and providing continuity of care. Their integration of medical professionals and resources facilitates efficient distribution and ensures adherence to quality standards in the industry.

Online stores segment is projected to witness fastest CAGR over the forecast period, driven by consumer demand for convenience and accessibility. Offering a diverse range of products, including contact lenses, and ocular health supplements, online platforms provide a seamless shopping experience and doorstep delivery. With features like virtual try-on tools and user reviews, they enhance the purchasing journey, empowering consumers to make informed decisions about their vision care needs. As e-commerce continues to expand, online stores are reshaping the retail landscape, catering to customers that are comfortable and skilled in using digital tools seeking convenience and variety in their care purchases.

Regional Insights

North America eye care industry dominated the overall global market and accounted for a 37.3% revenue share in 2025, driven by factors such as the large aging population, technological advancements in diagnostic and treatment options, increasing prevalence of vision problems due to digital device usage, greater awareness about ocular health, and improved healthcare access and insurance coverage. The region also benefits from a well-established healthcare infrastructure, high adoption of premium ophthalmic products, and strong presence of major market players focused on continuous innovation in vision care technologies. The market is also witnessing an increase in strategic collaborations aimed at expanding access to advanced eye care services and accelerating innovation. For instance, in April 2025, EyeCare Partners announced its participation at the ASCRS 2025 conference, highlighting collaborative clinical research and innovation initiatives focused on improving cataract and refractive surgery outcomes. The company emphasized cross-specialty collaboration among ophthalmologists and researchers to drive advancements in patient-centered eye care solutions.

U.S. Eye Care Market Trends

The eye care industry in the U.S. held a significant share in North America market in 2023, driven by demographic shifts towards an aging population, technological advancements in diagnostic and treatment options, increasing prevalence of vision problems due to digital device usage, awareness about ocular health, and improvements in healthcare access and insurance coverage for vision care services. The country also benefits from the strong presence of leading ophthalmic device manufacturers, established optometry networks, and rapid adoption of advanced technologies such as AI-enabled retinal imaging and minimally invasive ophthalmic surgeries. Growing demand for premium intraocular lenses (IOLs), contact lenses, and digital eye care solutions is further supporting market expansion.

Europe Eye Care Market Trends

The European eye care industry is fueled by an aging population, technological innovations in diagnostic and treatment modalities, rising prevalence of vision impairments due to lifestyle changes, increased awareness of eye health, and improvements in healthcare accessibility and insurance coverage for vision-related services. The region is witnessing increasing adoption of advanced cataract surgeries, premium lenses, and digital ophthalmology platforms aimed at enhancing diagnostic accuracy and patient outcomes. Favorable reimbursement frameworks and strong regulatory standards across several European countries are also encouraging the adoption of innovative ophthalmic products and therapies.

The eye care industry in the UK is influenced by demographic shifts towards an aging population, technological innovations in diagnostics and treatments, increasing awareness of eye health, and regulatory changes ensuring quality standards and access to vision care services. Rising prevalence of glaucoma, cataracts, and diabetic retinopathy is driving demand for advanced screening and treatment technologies across the country. In addition, the growing integration of AI-based diagnostic systems and NHS-supported eye screening initiatives is improving early disease detection and patient management. Increasing consumer preference for premium contact lenses and digital eye care services is also contributing to market growth.

The France eye care industry is growing due to shifting consumer preferences towards preventative care, a rise in digital eye strain, and the popularity of natural and organic products. Increasing awareness regarding ocular health and rising adoption of technologically advanced ophthalmic devices are further supporting market growth. The country is also witnessing growing demand for premium contact lenses, ocular supplements, and minimally invasive surgical procedures. In addition, government-supported healthcare access and strong ophthalmology research activities are contributing to innovation and wider adoption of advanced eye care solutions across France.

In July 2024, Topcon Healthcare partnered with French teleconsultation provider TESSAN to expand remote eye examination services and improve access to ophthalmic care through telemedicine-enabled solutions.

Asia Pacific Eye Care Market Trends

The Asia Pacific eye care industry is driven by the growing prevalence of eye diseases such as cataracts, glaucoma, and refractive errors, alongside the increasing age of populations and workforces. Technological advancements and government initiatives to improve healthcare infrastructure further boost market growth. Countries like India and China, with large populations and rising numbers of cataract surgeries, contribute significantly to this trend. However, challenges such as lack of awareness and rural accessibility hinder market expansion.

The eye care industry in Japan is experiencing significant growth, driven by an aging population, increasing awareness about eye health, and a cultural emphasis on preventive measures. The demand for products like vitamins and supplements is rising, alongside a preference for natural and organic ocular health items. Technological advancements, such as contact lenses with UV protection and moisture retention, and wearable technologies for vision management care, are also contributing to market expansion. In addition, Japan’s strong focus on innovation and precision healthcare is encouraging the development of advanced retinal imaging systems and robotic-assisted ophthalmic procedures. The presence of technologically advanced healthcare facilities and rising adoption of premium eye care products are further supporting the market’s growth trajectory.

The eye care industry in China is driven by an aging population, a rising middle class with higher disposable incomes, and increasing awareness about the importance of eye health. The market is seeing growth in demand for products like contact lenses, drops, and vitamins, spurred by the harmful effects of digital screens on eye health and government initiatives like the National Eye Health Program. With China having the world's largest population and a significant portion suffering from vision problems, the potential for ocular health products is vast. Rapid urbanization, expansion of private healthcare facilities, and growing investments in AI-enabled diagnostic technologies are also accelerating market growth. In addition, local and international companies are increasingly focusing on strategic partnerships and product innovation to strengthen their market presence in the country.

Latin America Eye Care Trends

The Latin America eye care industry is experiencing robust growth, primarily driven by the increasing demand for prescribed products among the elderly population due to the rising prevalence of eye disorders. Major players are enhancing their market presence through collaborations and acquisitions. The market is also influenced by the increased usage of digital devices, surging demand for prescribed spectacles, and the rising prevalence of vision impairment. Governments and healthcare organizations across the region are increasingly promoting eye health awareness programs and expanding access to ophthalmic care services. In addition, growing urbanization, improving healthcare infrastructure, and rising adoption of contact lenses and refractive surgeries are supporting long-term market development.

The eye care industry in Brazil is, driven by an aging population, a rising middle class with higher disposable incomes, and increasing awareness about the importance of eye health. The market is seeing growth in demand for products like contact lenses, drops, and vitamins, spurred by the harmful effects of digital screens on eye health and government initiatives like the National Eye Health Program. With China having the world's largest population and a significant portion suffering from vision problems, the potential for ocular health products is vast, further amplified by the country's rapid economic growth and urbanization.

Middle East & Africa Eye Care Market Trends

The Middle East and Africa (MEA) eye care industry is growing, driven by the increasing prevalence of age-related macular degeneration (AMD), and amblyopia, especially among the aging population, and the rise in disposable income leading to better access to healthcare services. Government initiatives focusing on health awareness and investment in modern diagnostic tools and surgical equipment are also significant drivers. In addition, the market benefits from the entry of international brands offering innovative solutions, including contact lenses and prescription glasses, catering to the region's unique needs.

The eye care industry in Saudi Arabia is experiencing significant growth, fueled by increasing awareness about eye health, a high prevalence of vision-related conditions, and the adoption of advanced technologies like contact lenses. The industry is also influenced by the country's young population, high disposable income, and the convenience offered by online platforms for purchasing products. Furthermore, government healthcare transformation initiatives under Vision 2030 support investments in advanced ophthalmic infrastructure and digital healthcare technologies. Rising prevalence of diabetes-related eye disorders and increasing demand for premium vision correction solutions are also driving market growth. In addition, expanding partnerships between healthcare providers and international ophthalmic companies are improving the availability of advanced diagnostic and surgical eye care services across the country.

Saudi Arabia is increasingly witnessing partnerships between healthcare providers and global life sciences companies to strengthen value-based ophthalmic care and improve patient access to advanced treatment solutions. For instance, recent collaborative initiatives between Roche KSA and King Khaled Eye Specialist Hospital have focused on supporting Vision 2030 goals through value-based eye care and improved ophthalmic services.

Key Eye Care Company Insights

The eye care industry is highly competitive, with several established ophthalmology, medical device, and pharmaceutical companies operating globally. Key market players are focusing on expanding their geographical presence, strengthening distribution networks, and increasing collaborations with hospitals, ophthalmology clinics, optical retail chains, and ambulatory surgical centers to improve product accessibility and patient reach.

Recent Developments

• In February 2026, Johnson & Johnson Vision launched ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM, expanding its premium contact lens portfolio with the first daily disposable multifocal toric lens designed for patients with both astigmatism and presbyopia. The launch reflects the company’s strategic focus on advanced vision correction technologies and growing demand for personalized contact lens solutions.

• In May 2025, EssilorLuxottica announced the acquisition of Optegra eye care clinics to expand its presence in medical ophthalmology and surgical eye care services. Through this acquisition, the company aims to integrate advanced diagnostics, surgical treatments, and comprehensive vision care services into a unified eye care platform.

• In December 2023,Carl Zeiss Meditec AG acquired Dutch Ophthalmic Research Center, for USD 1,052 million. This acquisition enhances ZEISS Medical Technology’s broad ophthalmic portfolio.

• In July 2023, Bausch + Lomb expanded its OTC product line by acquiring the Blink Eye Drops product line from Johnson & Johnson Vision for USD 106.5 million. This acquisition aligns with Bausch + Lomb's strategy to enhance consumer convenience in eye care, catering to the growing demand for dry eye relief. The Blink portfolio includes a range of eye and contact lens drops designed to provide immediate and lasting symptom relief, addressing a significant unmet need in the market.

Eye Care Market Report Scope

Global Eye Care Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global eye care market report based on product, mode of purchase, distribution channel, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Contact Lens

  • Intraocular Lens

  • Ocular Health Products

  • Others

• Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)

  • Over-The-Counter (OTC) Products

  • Prescribed (Rx) Products

• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals & Clinics

  • Retail Stores

  • Online Stores

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait